| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.91M | - | |
| VP | 79.5K | $767.2K | - | |
| VP | 67.4K | $650.3K | - | |
| VP | 65.1K | $628.0K | - | |
| VP | 56.3K | $543.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2016 | Chione Ltd61 | 10% Owner | Sell | 7,074 | $8.51 | $60,213.89 | - | |
| Jun 9, 2016 | Chione Ltd61 | 10% Owner | Sell | 45,541 | $9.21 | $419,283.58 | -0.3% | |
| Jun 7, 2016 | Chione Ltd61 | 10% Owner | Sell | 40,000 | $9.24 | $369,550.00 | -0.2% | |
| Jun 2, 2016 | Chione Ltd61 | 10% Owner | Sell | 17,855 | $9.65 | $172,243.61 | -0.2% | |
| Jun 1, 2016 | Chione Ltd61 | 10% Owner | Sell | 74,664 | $9.61 | $717,599.55 | -0.3% | |
| May 26, 2016 | Chione Ltd61 | 10% Owner | Sell | 46,122 | $9.73 | $448,828.43 | -0.3% | |
| May 23, 2016 | Chione Ltd61 | 10% Owner | Sell | 93,932 | $8.54 | $801,805.98 | -0.4% | |
| May 18, 2016 | Chione Ltd61 | 10% Owner | Sell | 63,800 | $8.15 | $519,968.14 | -0.4% | |
| May 16, 2016 | Chione Ltd61 | 10% Owner | Sell | 10,400 | $8.01 | $83,268.48 | - | |
| May 11, 2016 | Chione Ltd61 | 10% Owner | Sell | 31,868 | $8.24 | $262,647.73 | -0.2% |